Cargando…

LAG3 and its emerging role in cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Wang, Miao, Du, Qi, Jin, Jiangtao, Wei, Yuhan, Lu, Yuting, Li, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989707/ https://www.ncbi.nlm.nih.gov/pubmed/33784013 http://dx.doi.org/10.1002/ctm2.365

Ejemplares similares

Targeting breast cancer with a combination of DNT and LAG3 checkpoint blockage and its mechanism
por: Wang, Miao, et al.
Publicado: (2022)

New emerging targets in cancer immunotherapy: the role of LAG3
por: Puhr, Hannah Christina, et al.
Publicado: (2019)

The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022)

Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib
por: Lu, Yuting, et al.
Publicado: (2021)

A Lagging Lock: Hair Cycle Abnormalities in Follicular Vitiligo?
por: Gopinath, Hima, et al.
Publicado: (2017)

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
por: Cai, Letong, et al.
Publicado: (2023)

Tamoxifen-induced endometrial carcinoma after a lag of 14 years
por: Dhull, Anil Kumar, et al.
Publicado: (2013)

The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy
por: Long, Long, et al.
Publicado: (2018)

Testin and its emerging modulatory role in systemic carcinogenesis
por: Kapoor, Shailendra
Publicado: (2012)

The Linear-No-Threshold Line for Cancer Excess Relative Risk Based on Lagging Low Radiation Doses is Misleading
por: Scott, Bobby R.
Publicado: (2021)

Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
por: Cai, Letong, et al.
Publicado: (2023)

Time lag between oscillatory pressure and flow affecting accuracy of forced oscillation technique
por: Ohishi, Junichi, et al.
Publicado: (2011)

Applying the Distributed Lag Non-Linear Model (DLNM) in Epidemiology: Temperature and Mortality in Mashhad
por: ENTEZARI, Alireza, et al.
Publicado: (2019)

Curcumin and Its Emerging Role in Pain Modulation and Pain Management
por: Kapoor, Shailendra
Publicado: (2012)

Why is immunotherapy for glioblastoma “Lag”-ging
por: Mathios, Dimitrios, et al.
Publicado: (2019)

The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application
por: Huo, Jin-Ling, et al.
Publicado: (2022)

Clinical observation of the efficacy of PD‐1/PD‐L1 inhibitors in the treatment of patients with advanced solid tumors
por: Wang, Miao, et al.
Publicado: (2021)

Cross-lagged analysis of the interplay between meaning in life and positive mental health during the COVID-19 epidemic
por: Yu, Yongjuan, et al.
Publicado: (2020)

Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies
por: Kapoor, Shailendra
Publicado: (2012)

Propolis and it's emerging anti-neoplastic effects: beyond its role in oral dysplasia
por: Kapoor, Shailendra
Publicado: (2015)

Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma
por: Ma, Dongshen, et al.
Publicado: (2022)

LAG3 in gastric cancer: it’s complicated
por: Ulase, Dita, et al.
Publicado: (2023)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

Biosecurity and biosafety in research on emerging pathogens
por: Lu, Lu, et al.
Publicado: (2012)

Emerging Anti Carcinogenic Applications of Nimesulide: Therapeutic Benefits Beyond Its Primary Role in Pain Management
por: Kapoor, Shailendra
Publicado: (2012)

Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies
por: Gide, Tuba N., et al.
Publicado: (2023)

LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy
por: Ibrahim, Rebecca, et al.
Publicado: (2023)

sMICA and its emerging role as a prognostic and diagnostic indicator in systemic malignancies besides hepatocellular carcinoma
por: Kapoor, Shailendra
Publicado: (2013)

Why Are Genes Encoded on the Lagging Strand of the Bacterial Genome?
por: Chen, Xiaoshu, et al.
Publicado: (2013)

Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined
por: Li, Heming, et al.
Publicado: (2023)

Pharmacogenomics of sevoflurane: role in emergence delirium
por: Nair, Abhijit
Publicado: (2019)

Vitamin C and Its Emerging Role in Pain Management: Beneficial Effects in Pain Conditions Besides Post Herpetic Neuralgia
por: Kapoor, Shailendra
Publicado: (2012)

Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer
por: Xiang, Yi, et al.
Publicado: (2022)

SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)
por: Gauci, Marie-Léa, et al.
Publicado: (2021)

Seroprevalence of Chikungunya Virus after Its Emergence in Brazil
por: Gérardin, Patrick, et al.
Publicado: (2018)

Pentraxin 3: Potential prognostic role in SARS-CoV-2 patients admitted to the emergency department
por: Schirinzi, Annalisa, et al.
Publicado: (2021)

The Accelerated Evolution of Lagging Strand Genes Is Independent of Sequence Context
por: Merrikh, Christopher N., et al.
Publicado: (2016)

A first case report of using chimeric antigen receptor T-cell immunotherapy to treat high-risk smoldering multiple myeloma
por: Liu, Yang, et al.
Publicado: (2023)

Smoking signature as a biomarker for immunotherapy
por: Li, Mengqian, et al.
Publicado: (2022)

Comment on “Abscopal effect in the radio and immunotherapy”
por: Fabi, François
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5f05dmb2imuu1cmo62k36t82s1